Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

74.78 +3.52 (+4.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
31 32 Next >
Cathie Wood's Buying These 3 Stocks Hand Over Fist
A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team. 
Via The Motley Fool
$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Why Is Illumina Stock Trading Lower Today?
Illumina Inc (NASDAQ: ILMN) shares are trading lower after the company appointed Jacob Thaysen as its new CEO, roughly three months after the company parted ways  
Via Benzinga
11 Analysts Have This to Say About Illumina
Via Benzinga
Wall Street Thinks Illumina Stock Will Rise 27% in 1 Year. Here's Why That Probably Won't Happen.
Its core revenue won't grow, and that's not even its biggest problem at the moment. 
Via The Motley Fool
Peering Into Illumina's Recent Short Interest
Via Benzinga
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
Elliott Wave Technical Analysis: Illumina Inc.
Looking for shorts with invalidation at $195. 
Via Talk Markets
The Latest Analyst Ratings for Illumina
Via Benzinga
Illumina Unusual Options Activity
Via Benzinga
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Illumina's future is looking a bit dim at the moment. 
Via The Motley Fool
(ILMN) - Analyzing Illumina's Short Interest
Via Benzinga
$100 Invested In Illumina 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Looking Into Illumina's Recent Short Interest
Via Benzinga
Why Illumina Shares Are Falling Today
Illumina Inc (NASDAQ: ILMN) disclosed in an SEC filing that the Securities and Exchange Commission is the latest government agency investigating the company's  
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Illumina To Bear The Brunt Of Slowdown In Consumables Purchasing Amid Lower Demand In China: Analyst
Stifel analyst Daniel Arias reiterated a Buy rating on Illumina, Inc (NASDAQ: ILMN), 
Via Benzinga
Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining around 350 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Nasdaq, S&P 500 Futures Rally Ahead Of Inflation Data; Why This Analyst Sounds Out Caution About Stock Valuations
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Here's How Much You Would Have Made Owning Illumina Stock In The Last 20 Years
Via Benzinga
Disney, Alibaba And 3 Stocks To Watch Heading Into Thursday
With U.S. stock futures trading higher this morning on Thursday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Illumina Stock Crumbles As Earnings Guidance Completely Misses Forecasts
Illumina beat second-quarter expectations, but earnings guidance completely missed. 
Via Investor's Business Daily
US Stocks Walk Inflation Tightrope As Futures Point To Cautious Recovery: Why This Analyst Downplays Fed Rate Worries
Stocks could recover on Wednesday from Thursday's weakness, spearheaded by tech and financial stocks, but traders could show restraint. 
Via Benzinga
BNGO Stock Alert: Bionano Just Reverse Split Its Stock
Bionano was a hot genetic analysis stock two years ago but now needed a reverse split so that BNGO stock could stay listed on the Nasdaq. 
Via InvestorPlace
Week In Review: Pyrotech Closes $97 Million Series A Round For Immunomodulator Drugs
Beijing’s Pyrotech Therapeutics completed a $97 million Series A funding to develop novel small molecule drugs that modulate immune responses for autoimmune diseases. Meanwhile, Mirxes Holding closed a... 
Via Talk Markets
Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil
There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today. 
Via InvestorPlace
Agrigenomics Market Is Booming Worldwide : Illumina, LGC, Eurofins USA
Stay up-to-date with Agrigenomics Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Exposures COVID-19
Next Generation Sequencing Market Projected to Show Strong Growth : Life Technology, Biomatters, CLC Bio, GATC Biotech
Get an extensive Next Generation Sequencing Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry. 
Via SBWire
Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: ILMN) is not even as good as Danaher Corporation (NYSE: DHR). 
Via Benzinga
Shady Business: 3 Well-Known Stocks That Deserve to Be on Your Blacklist
Corporate America is littered with popular companies that have been fined for running afoul of the law. Here are three shady stocks to avoid. 
Via InvestorPlace
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.